Vera Therapeutics, Inc.
VERA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831828
In the last 90 days, Vera Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 219 institutions reported holding it in 13F filings for Q2 2026, worth $3.34B in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Vera Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 51 | 55 | +4 |
| Shares | 20.4M | 21.5M | +1.14M (+5.6%) |
| Value | $277.6M | $459.0M | +$181.4M (+65.3%) |
New holders (7)
Institutions that held Vera Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Woodline Partners LP | 169,277 | $3.61M | 0.05% |
| Eversept Partners, LP | 156,129 | $3.33M | 0.39% |
| Point72 Asset Management, L.P. | 121,000 | $2.58M | 0.01% |
| Gyon Technologies Capital Management, LP | 20,431 | $435.0K | 0.14% |
| State of Wisconsin Investment Board | 15,051 | $321.0K | 0.00% |
| BNP Paribas Arbitrage, SA | 5,183 | $110.5K | 0.00% |
| Cubist Systematic Strategies, LLC | 5,000 | $107.0K | 0.00% |
Sold out (3)
Institutions that held Vera Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Bank of Montreal | 96,849 | $1.41M |
| Dynamic Technology Lab Private Ltd | 11,939 | $162.0K |
| State of Wyoming | 28 | $0 |